APA citiranje

Datta, J., Berk, E., Cintolo, J. A., Xu, S., Roses, R. E., & Czerniecki, B. J. (2015). Rationale for a Multimodality Strategy to Enhance the Efficacy of Dendritic Cell-Based Cancer Immunotherapy. Front Immunol.

Citação norma Chicago

Datta, Jashodeep, Erik Berk, Jessica A. Cintolo, Shuwen Xu, Robert E. Roses, and Brian J. Czerniecki. "Rationale for a Multimodality Strategy to Enhance the Efficacy of Dendritic Cell-Based Cancer Immunotherapy." Front Immunol 2015.

MLA citiranje

Datta, Jashodeep, et al. "Rationale for a Multimodality Strategy to Enhance the Efficacy of Dendritic Cell-Based Cancer Immunotherapy." Front Immunol 2015.